TJ08 is a 1,2,5-trisubstituted benzimidazole derivative with anticancer properties that effectively induces G1/S phase blockade while promoting apoptotic effects in a variety of cancer cells.
Molecular Weight:
405.38
CAS Number:
[2924274-19-9]
Formula:
C22H16FN3O4
* VAT and and shipping costs not included. Errors and price changes excepted